Loading...
The FDA has approved generic versions of the antiepileptic Topamax (topiramate). Seventeen companies now have the right to market the drug.
The agency notes that physicians should monitor patients' serum bicarbonate levels while they take topiramate, since the drug has been linked to metabolic acidosis. Other side effects include acute myopia and secondary angle closure glaucoma.
The labels of generic topiramate will differ from that of Topamax because some of the drug's uses are still protected under patents and exclusivity.
Comment
LINK(S):
FDA news release (Free)
Topamax label (Free PDF)